0000904454-13-000847.txt : 20130731
0000904454-13-000847.hdr.sgml : 20130731
20130731170002
ACCESSION NUMBER: 0000904454-13-000847
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130715
FILED AS OF DATE: 20130731
DATE AS OF CHANGE: 20130731
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ocera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001274644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 631192270
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12651 HIGH BLUFF DRIVE
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-436-3900
MAIL ADDRESS:
STREET 1: 12651 HIGH BLUFF DRIVE
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: TRANZYME INC
DATE OF NAME CHANGE: 20031230
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BLAIR JAMES C
CENTRAL INDEX KEY: 0001024000
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35119
FILM NUMBER: 13999743
MAIL ADDRESS:
STREET 1: 5880 PACIFIC CENTER BLVD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121-4204
4/A
1
edgar.xml
PRIMARY DOCUMENT
X0306
4/A
2013-07-15
2013-07-16
0001274644
Ocera Therapeutics, Inc.
OCRX
0001024000
BLAIR JAMES C
C/O DOMAIN ASSOCIATES, LLC
ONE PALMER SQUARE
PRINCETON
NJ
08542
0
0
1
0
Common Stock
2013-07-15
4
P
0
988285
6.0264
A
988285
I
By Domain Partners VIII, L.P.
Common Stock
2013-07-15
4
P
0
7333
6.0264
A
7333
I
By DP VIII Associates, L.P.
Common Stock
2013-07-15
4
P
0
331873
6.0264
A
1857036
I
By Domain Partners VI, L.P.
Common Stock
15731
I
By DP VI Associates, L.P.
Common Stock
47963
I
By Domain Associates, LLC
The Reporting Person is a Managing Member of (i) One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P., (ii) One Palmer Square Associates VI, LLC, which is the sole general partner of Domain Partners VI, L.P. and DP VI Associates, L.P., and (iii) Domain Associates, LLC. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
The Issuer changed its name from Tranzyme, Inc. [TZYM] to Ocera Therapeutics, Inc. on July 15, 2013. This amendment is being filed to restate the original form in its entirety, to correct an error with respect to the reporting of Warrants to Purchase Common Stock held by Domain Partners VI, L.P.
/s/Kathleen K. Schoemaker, Attorney-in-Fact
2013-07-30